Research Article
Pediatric COVID-19: Correlations between Clinical and Imaging Perspectives
Table 3
Comparison between the clinical and radiological characteristics of the studied patients with and without comorbidities.
| Variables | COVID-19 patients without comorbidities | COVID-19 patients with comorbidities | | | |
| Wheezes | 18 (45.0%) | 32 (80.0%) | <0.001 | Respiratory distress | 15 (37.5%) | 32 (80.0%) | 0.001 | Respiratory rate, | | | | Range | 16–55 | 16–55 | 0.008 | Cardiac manifestations | 6 (15.0%) | 22 (55.0%) | 0.003 | Clinical severity | | | | Mild | 9 (22.5%) | 3 (7.5%) | | Moderate | 19 (47.5%) | 3 (7.5%) | | Severe | 10 (25.0%) | 18 (45.0%) | <0.001 | Critical | 2 (5.0%) | 16 (40.0%) | | Intensive care unit admission | 10 (25.0%) | 35 (87.5%) | <0.001 | Mechanical ventilation | 1 (2.5%) | 27 (67.5%) | <0.001 | Mortality | 1 (2.5%) | 12 (30.0%) | 0.004 | COVID-19 severity assessment score | | | | Median (IQR) | 3 (0–5) | 4 (2–5) | 0.212 | Range | 0–6 | 0–6 | | Abnormal radiological findings | 16 (40.0%) | 29 (72.5%) | 0.005 | Lesion size and density | | | 0.029 | Ground-glass opacities (GGOs) | 7 (17.5%) | 8 (20.0%) | Consolidation | 3 (7.5%) | 16 (40.0%) | Ground-glass opacities (GGOs) and consolidation | 3 (7.5%) | 4 (10.0%) | Bronchiectasis changes | 1 (2.5%) | 0 (0.0%) | Number of lobes affected | | | 0.018 | Median (IQR) | 0 (0–3) | 3 (0–4) | Range | 0–6 | 0–6 | The affected lung sides | | | 0.024 | No | 26 (65.0%) | 9 (22.5%) | Bilateral | 10 (25.0%) | 26 (65.0%) | Unilateral | 4 (10.0%) | 5 (12.5%) | RSNA expert consensus statement | | | 0.046 | Negative | 26 (65.0%) | 9 (22.5%) | Indeterminate | 10 (25.0%) | 14 (35.0%) | Atypical | 4 (10.0%) | 10 (25.0%) | Typical | 0 (0.0%) | 7 (17.5%) | Chest X-ray score | | | 0.005 | Median (IQR) | 0 (0–3) | 4 (0–4) | Range | 0–6 | 0–6 | RAPID-COVID score | | | <0.001 | Median (IQR) | 1 (1–2) | 5 (2–6) | Range | 1–6 | 1–8 | Chest CT severity score (CT-SS) | | | 0.002 | Median (IQR) | 0 (0–10) | 12 (0–24) | Range | 0–32 | 0–32 |
|
|
RSNA: Radiological Society of North America Expert Consensus Statement. is significant; is highly significant. |